Ginkgo Bioworks’ Acquisition of StrideBio’s Gene Therapy Assets

Martina Bellini
Tagged:

Foley Hoag represented Ginkgo Bioworks on the deal.Ginkgo Bioworks (NYSE: DNA) (“Ginkgo”), the leading platform for cell programming and biosecurity, announced its acquisition of StrideBio’s adeno-associated virus…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now